Access Bio Stock Debt To Equity
950130 Stock | KRW 6,260 120.00 1.88% |
Access Bio fundamentals help investors to digest information that contributes to Access Bio's financial success or failures. It also enables traders to predict the movement of Access Stock. The fundamental analysis module provides a way to measure Access Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Access Bio stock.
Access |
Access Bio Company Debt To Equity Analysis
Access Bio's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Access Bio Debt To Equity | 0.13 % |
Most of Access Bio's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Access Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition |
According to the company disclosure, Access Bio has a Debt To Equity of 0.13%. This is 99.76% lower than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The debt to equity for all Republic of Korea stocks is 99.73% higher than that of the company.
Access Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Access Bio's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Access Bio could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics of similar companies.Access Bio is currently under evaluation in debt to equity category among related companies.
Access Fundamentals
Return On Equity | 108.02 | |||
Return On Asset | 0.35 | |||
Profit Margin | 0.40 % | |||
Operating Margin | 0.55 % | |||
Current Valuation | 1.03 T | |||
Shares Outstanding | 26.79 M | |||
Shares Owned By Insiders | 25.25 % | |||
Shares Owned By Institutions | 0.08 % | |||
Price To Earning | 149.71 X | |||
Price To Sales | 1.44 X | |||
Revenue | 441.37 M | |||
Gross Profit | 90.63 B | |||
EBITDA | 69.95 B | |||
Net Income | 166.09 M | |||
Cash And Equivalents | 167.93 M | |||
Cash Per Share | 828.78 X | |||
Total Debt | 10.13 M | |||
Debt To Equity | 0.13 % | |||
Current Ratio | 16.48 X | |||
Book Value Per Share | 2,289 X | |||
Cash Flow From Operations | 137.9 M | |||
Number Of Employees | 69 | |||
Beta | 0.28 | |||
Market Capitalization | 292.03 B | |||
Total Asset | 372.85 M | |||
Retained Earnings | 18.8 B | |||
Working Capital | 43.68 B | |||
Current Asset | 45.78 B | |||
Current Liabilities | 2.1 B | |||
Net Asset | 372.85 M |
About Access Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Access Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Access Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Access Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |